參考文獻/References:
[1] DE SIMONE M,CHOUCHA A,CIAGLIA E,et al.Discogenic low back pain:anatomic and pathophysiologic characterization,clinical evaluation,biomarkers,AI,and treatment options[J].J Clin Med,2024,13(19):5915.
[2] BEATTIE P F.Current understanding of lumbar intervertebral disc degeneration:a review with emphasis upon etiology,pathophysiology,and lumbar magnetic resonance imaging findings[J].J Orthop Sports Phys Ther,2008,38(6):329-340.
[3] PYE S R,REID D M,LUNT M,et al.Lumbar disc degene-ration:association between osteophytes,end-plate sclerosis and disc space narrowing[J].Ann Rheum Dis,2007,66(3):330-333.
[4] TESSIER S,TRAN V A,OTTONE O K,et al.TonEBP-deficiency accelerates intervertebral disc degeneration underscored by matrix remodeling, cytoskeletal rearrangements,and changes in proinflammatory gene expression[J].Matrix Biol,2020,87:94-111.
[5] 何嘉輝,甘延池,龔焱,等.龜板通過抑制炎癥反應(yīng)改善小鼠軟骨終板退變[J].中國骨質(zhì)疏松雜志,2023,29(7):949-952.
[6] AMELOT A,MAZEL C.The intervertebral disc:physiology and pathology of a brittle joint[J].World Neurosurg,2018,120:265-273.
[7] WU P H,KIM H S,JANG I T.Intervertebral disc diseases part 2:a review of the current diagnostic and treatment strategies for intervertebral disc disease[J].Int J Mol Sci,2020,21(6):2135.
[8] 岑芊瑤,劉江源,曾慶賀,等.補腎活血方聯(lián)合人臍帶血間充質(zhì)干細胞修復(fù)小鼠膝關(guān)節(jié)軟骨缺損的實驗研究[J].中醫(yī)正骨,2023,35(12):5-13.
[9] HU S,GE Q,XIA C,et al.Bushenhuoxue formula accele-rates fracture healing via upregulation of TGF-β/Smad2 signaling in mesenchymal progenitor cells[J].Phytomedicine,2020,76:153256.
[10] DONG R,YING J,XU T,et al.Bushenhuoxue formula facilitates articular cartilage repair and attenuates matrix degradation by activation of TGF-β signaling pathway[J].Evid Based Complement Alternat Med,2018,2018:2734581.
[11] NAIR A B,JACOB S.A simple practice guide for dose conversion between animals and human[J].J Basic Clin Pharm,2016,7(2):27-31.
[12] ZHOU C,YAO S,FU F,et al.Morroniside attenuates nucleus pulposus cell senescence to alleviate intervertebral disc degeneration via inhibiting ROS-Hippo-p53 pathway[J].Front Pharmacol,2022,13:942435.
[13] MAERZ T,NEWTON M,MAREK A A,et al.Dynamic adaptation of vertebral endplate and trabecular bone following annular injury in a rat model of degenerative disc disease[J].Spine J,2018,18(11):2091-2101.
[14] XIE Y,ZHANG J,YANG S,et al.Role of Bushen Huoxue Formula and transplanted endothelial progenitor cells play in promoting endplate microcirculation and attenuating intervertebral disc degeneration[J].Heliyon,2024,10(6):e28095.
[15] URBAN J P,SMITH S,FAIRBANK J C.Nutrition of the intervertebral disc[J].Spine(Phila Pa 1976),2004,29(23):2700-2709.
[16] SUN Y,LI Z,DUAN J,et al.From structure to therapy:the critical influence of cartilaginous endplates and microvascular network on intervertebral disc degeneration[J].Front Bioeng Biotechnol,2024,12:1489420.
[17] XIN J,WANG Y,ZHENG Z,et al.Treatment of intervertebral disc degeneration[J].Orthop Surg,2022,14(7):1271-1280.
[18] 羅海杰,柯松堅,林彩娜,等.運動訓(xùn)練對椎間盤退變模型大鼠疼痛及細胞外基質(zhì)合成的影響[J].中國組織工程研究,2017,21(20):3176-3182.
[19] ROUGHLEY P J.Biology of intervertebral disc aging and degeneration:involvement of the extracellular matrix[J].Spine(Phila Pa 1976),2004,29(23):2691-2699.
[20] 姚之肖.Salubrinal在人髓核細胞中抑制IL-17介導(dǎo)的椎間盤退變機制的研究[D].濟南:山東大學(xué),2017.
[21] LING H,ZENG Q,GE Q,et al.Osteoking decelerates cartilage degeneration in DMM-induced osteoarthritic mice mo-del through TGF-β/smad-dependent manner[J].Front Pharmacol,2021,12:678810.
[22] XIONG Y,YANG Y L,GAO Y S,et al.Histological changes of cervical disc tissue in patients with degenerative ossification[J].J Korean Neurosurg Soc,2022,65(2):186-195.
[23] HU B,XU C,CAO P,et al.TGF-beta stimulates expression of chondroitin polymerizing factor in nucleus pulposus cells through the Smad3,RhoA/ROCK1,and MAPK signaling pathways[J].J Cell Biochem,2018,119(1):566-579.
[24] 鄭冬陽,于靜,金明秀.基于腎藏精主骨生髓論治骨關(guān)節(jié)炎[J].光明中醫(yī),2023,38(22):4347-4349.
[25] 胡雪琴,金紅婷,施振宇,等.髓病理論及其在骨病學(xué)中的應(yīng)用[J].中醫(yī)正骨,2018,30(11):39-42.
[26] 胡雪琴,金紅婷,肖魯偉,等.“浙派中醫(yī)”骨傷學(xué)家肖魯偉辨治“髓系骨病”的學(xué)術(shù)經(jīng)驗[J].浙江中醫(yī)藥大學(xué)學(xué)報,2019,43(10):1071-1073.
[27] 郭澤華,李兆勇,陳龍,等.補腎活血方促進脂肪間充質(zhì)干細胞類髓核分化的作用機制[J].中國組織工程研究,2024,28(25):3974-3980.
[28] 李凱明,朱立國,李玲慧,等.補腎活血方對兔退變椎間盤模型經(jīng)典Wnt/β-catenin信號通路的影響[J].中華中醫(yī)藥雜志,2020,35(12):6001-6005.
相似文獻/References:
[1]徐幫杰,楊楠,白偉杰,等.坐位定點旋轉(zhuǎn)整復(fù)法治療腰椎間盤突出癥的療效觀察[J].中醫(yī)正骨,2015,27(11):17.
XU Bangjie,YANG Nan,BAI Weijie,et al.Observation on the curative effect of fixed-point rotational reduction in sitting position in the treatment of lumbar disc herniation[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):17.
[2]白春曉,賈育松,孫旗,等.中醫(yī)藥在腰椎間盤突出癥圍手術(shù)期應(yīng)用的研究進展[J].中醫(yī)正骨,2015,27(11):65.
[3]王少純,周英杰.郭維淮教授運用活血益氣通經(jīng)湯治療腰椎間盤突出癥的經(jīng)驗[J].中醫(yī)正骨,2015,27(11):75.
[4]鄧紅軍.硫酸鈣骨水泥椎體成形聯(lián)合后路短節(jié)段椎弓根螺釘
內(nèi)固定治療創(chuàng)傷性胸腰椎骨折[J].中醫(yī)正骨,2015,27(10):35.
[5]張莉,秦丹霞,張細姣.腹針治療椎間盤源性腰痛[J].中醫(yī)正骨,2015,27(10):38.
[6]蘇洪,張雪林.患側(cè)下肢牽引配合腰椎斜扳法治療
極外側(cè)型腰椎間盤突出癥[J].中醫(yī)正骨,2015,27(10):40.
[7]吳青坡,孫國紹,王林杰.后路椎管減壓聯(lián)合腰椎椎弓根釘動態(tài)穩(wěn)定裝置內(nèi)固定
治療單節(jié)段腰椎退行性疾病[J].中醫(yī)正骨,2015,27(10):42.
[8]謝冬群,黃中梁,葉金麗.加強隔附子餅灸治療腎陽虛型腰椎間盤突出癥的
臨床研究[J].中醫(yī)正骨,2015,27(09):18.
XIE Dongqun,HUANG Zhongliang,YE Jinli.Clinical study on intensive aconite root cake separated moxibustion in the treatment of kidney-yang-deficiency-type lumbar disc herniation[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):18.
[9]沈海良,錢萬鋒,周驍棟.針刀松解聯(lián)合局部封閉與口服中藥治療腰椎間盤突出癥[J].中醫(yī)正骨,2015,27(09):46.
[10]王仁燦,黃炎洪,潘偉江,等.45°肩踝懸吊牽引下撞擊腰椎療法治療L5S1椎間盤突出癥[J].中醫(yī)正骨,2015,27(08):51.
[11]桑廷瑞,王想福,李晨旭,等.腰椎間盤突出癥中醫(yī)證候與Pfirrmann分級的關(guān)系探討[J].中醫(yī)正骨,2022,34(02):51.